Many stem cell transplants have been curative with a 90% survival but only 18% of eligible patients have an acceptable match.The multicenter trials of hydroxyurea in the 1980s and 90s as preventive therapy reduced the need for blood transfusions, pain events and hospitalizations. This was approved for medical use by the FDA in 1998.These two major events bring hope to all those battling the sickle cycle of recurrent pain and complications. It looks at the challenges across all aspects of the sickle cell condition; from pre-conception to living and caring for people with the sickle cell condition and their families.Currently, there are 198 active research studies listed at We have come a long way in 40 years but more is needed to bring a cure for all. This paper is a report on Sickle Cell Advocacy Project in the three Northern regions of Ghana, executed by by SICCA in collaboration with the Ministries of Health and Education and endorsed by the Ghana Academy of Arts and Sciences.
TV and Billboard adverts, Banners, Flyers, Posters, Presentations using Projector and Screen and ‘T’- shirts were all used to intensify the advocacy.
By the early 1990s, the Cooperative Study of Sickle Cell Disease estimated a median life expectancy of those with sickle cell anemia, the most severe form of the disease, of 42 years of age for males and 48 years of age for females. https://gov/fdavoice/index.php/2017/09/making-advances-against-sickle-cell-disease/# L-glutamine oral powder https://gov/Drugs/Information On Drugs/Approved Drugs/ucm566097N Engl J Med 2017; 38-855 March 2, 2017
In 2005 Lanzkron et al confirmed these findings of a significant decrease in mortality for children with SCD, but mortality for adults increased during the same time period. query=featured_home Sickle Cell Disease Update form the ASH meeting in December 27, 2017 cell patients fight uphill battle for research, treatment — and compassion Jenny Gold — Kaiser Health News December 26, 2017 https:// Sickle Cell Disease Advocacy In Ghana: Experiences From An African Country.
People saw the need for screening to know their sickle cell status to make informed choices before having children. RECOMMENDATIONS New Resource – Blood Transfusion in Sickle Cell Educational videos The Centers for Disease Control and Prevention (CDC) along with the Georgia Health Policy Center (GHPC) are pleased to announce a four-part educational video series for healthcare providers.
The series, which will be housed on GHPC’s website, is designed to provide information about the strategies for reducing transfusion complications in people with sickle cell disease (SCD).